Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension

NCT00219596 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open Angle
Ocular Hypertension

Interventions

DRUG: Xalacom
DRUG: unfixed Latanoprost and Timolol

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.